go-v.orgdoi

Validation the role of desmocollin-2 in osteosarcoma based on single cell and bulk RNA seq and experimental analyses

Jiaxing Zeng, Yu Sun, Yu-Nan Man, Haijun Tang, Long Xie, Maolin He · Journal of Cancer · 2023

  • DOI 10.7150/jca.87411
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2023

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2023

Abstract

Background: The aetiology of osteosarcoma (OS) remains unclear.Desmocollin-2 (DSC2) mediates intercellular adhesion and is involved in tumour progression.Therefore, we aim to investigate the potential role of DSC2 in OS.Methods: We analyzed the expression, prognostic value and immune infiltration of DSC2 in OS via single cell and bulk RNA seq data.Besides, the expression and function of DSC2 in OS were further verified by in vitro experiment.Results: We preliminarily determined that DSC2 was high expressed in OS, which was a risk factor for survival and had a strong relationship with immune cell infiltration.What's more, in vitro experiments also demonstrated that DSC2 was high expressed in OS cells, and silencing DSC2 would suppress proliferation, migration and invasion of OS cells.Conclusions: DSC2 may serve as an oncogene, which exerts a crucial role in tumor progression, predicting prognosis and immune cell infiltration in OS.

Open the resolved locator · 10.7150/jca.87411

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 18:28 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v14p2619.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.